The down-regulation of HLA-DM gene expression in rheumatoid arthritis is not related to their promoter polymorphism

Journal of Immunology

Volumn 165, Issue 9, 2000, Pages 4861-4869

  Louis Plence, P ^a   Kerlan Candon, S ^a   Morel, J ^a   Combe, B ^a   Clot, J ^a   Pinet, V ^a   Eliaou, J F ^a  

^a HÔPITAL SAINT ELOI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA DM ANTIGEN; HLA DR ANTIGEN;

ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE EXPRESSION; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SEQUENCE ANALYSIS;

EID: 0034327257     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.9.4861     Document Type: Article

References (43)

1. Processing and presentation of endocytically acquired protein antigens by MHC class II and class I molecules
2. Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding
3. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments
4. Invariant chain targets HLA class II molecules to acidic endosomes containing intemalized influenza virus
5. In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides
6. Selective release of some invariant chain-derived peptides from HLA-DR1 molecules at endosomal pH
7. Self-release of CLIP in peptide loading of HLA-DR molecules
8. Structural features of the invariant chain fragment CLIP controlling rapid release from HLA-DR molecules and inhibition of peptide binding
9. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules
10. HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells
11. HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading
12. Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLA-DM
13. Mediation by HLA-DM of dissociation of peptides from HLA-DR
14. DM enhances peptide binding to class II MHC by release of invariant chain derived peptide
15. HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH
16. Variation in HLA-DM expression influences conversion of MHC class II αβ: Class II-associated invariant chain peptide complexes to mature peptide-bound class II αβ dimers in a normal B cell line
17. Editing of the HLA-DR-peptide- repertoire by HLA-DM
18. How HLA-DM affects the peptide repertoire bound to HLA-DR molecules
19. Unexpected reactivities of T-cells selected by a single MHC-peptide ligand
20. HLA-DMA and HLA-DMB gene expression functions through the conserved S-X-Y region
21. The DMB promoter: Delineation, in vivo footprint, trans-activation, and trans-dominant suppression
22. The two novel MHC class II transactivators RFX5 an CIITA both control expression of HLA-DM genes
23. differential expression of related HLA class II DQ β genes caused by nucleotide variation in transcriptional regulatory elements
24. Allelic polymorphism in transcriptional regulatory regions of HLA-DQB genes
25. Differential transcriptional activities of HLA-DR genes in the various haplotypes
26. Polymorphism in the promoter region of HLA-DRB genes
27. HLA DR, DQ, and DP antigen expression in rheumatoid synovial cells: A biochemical and quantitative study
28. Increase of class II HLA molecules on the membrane of B lymphocytes from patients with rheumatoid arthritis
29. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis
30. The molecular basis of susceptibility of rheumatoid arthritis
31. Polymorphism of the HLA-DMA and DMB genes in rheumatoid arthritis
32. Genomic organization of all six class II families in the human major histocompatibility complex
33. Quantitative analysis of the expression of the HLA-DRB genes at transcriptional level by competitive polymerase chain reaction
34. Formation of a regulatory factor X/X2 box-binding protein/nuclear factor-Y multiprotein complex on the conserved regulatory regions of HLA class II genes
35. Temporal and subunit-specific modulations of the Rel/NF-κB transcription factors through CD28 costimulation
36. HLA-DM: An endosomal and lysosomal chaperone for the immune system
37. Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM
38. Novel mutants define genes required for the expression of human histocompatibility leukocyte antigen DM: Evidence for loci on human chromosome 6p
39. HLA-DM is present in one-fifth of the amount of HLA-DR in the class II peptide-loading compartments where it associates with leupeptin-induced peptide (LIP)-HLA-DR complexes
40. T-cell responses in rheumatoid arthritis: Systemic abnormalities-local disease
41. Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell
42. HLA-DR10 motifs that carry susceptibility to rheumatoid arthritis bind 70-kD heat shock proteins
43. The HSC73 molecular: Involvement in MHC class II antigen presentation